3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News

Telemedicine Platform Yields Notable, Lasting Weight Loss

A real-world study finds that adults with obesity or overweight and related comorbidities who receive antiobesity medications through a telehealth clinic achieve substantial long-term weight loss.

Childhood Oral Health Linked to Cardiovascular Disease Later in Life

Kids with numerous dental problems and severe gingivitis were up to 45% more likely to have a heart attack, stroke, or coronary artery disease as adults than kids with less oral disease.

Can Medicine Make Us Live to 150?

Clinical advances in transplants, geroprotective drugs, and metabolomic clocks are shifting focus from lifespan to healthspan — but major biological and ethical limits remain.

Heart Scans Reveal Hidden Health Issues in Many Older Adults

Advanced heart scans and routine health checks reveal previously unknown heart and other health issues in a vast majority of older adults.

Semaglutide Boosts Insulin Sensitivity in Schizophrenia Care

Semaglutide can mitigate antipsychotic-induced metabolic dysfunction in patients with schizophrenia, prediabetes, and overweight or obesity on second-generation antipsychotics.

1 in 4 Kids at Juvenile Arthritis Onset Have Renal Issues

Acute kidney injury occurs in nearly one quarter of children at the onset of juvenile idiopathic arthritis and increases the risk for long-term kidney damage by more than five times.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Latest News

A real-world study finds that adults with obesity or overweight and related comorbidities who receive antiobesity medications through a telehealth clinic achieve substantial long-term weight loss.

Kids with numerous dental problems and severe gingivitis were up to 45% more likely to have a heart attack, stroke, or coronary artery disease as adults than kids with less oral disease.

Clinical advances in transplants, geroprotective drugs, and metabolomic clocks are shifting focus from lifespan to healthspan — but major biological and ethical limits remain.

Advanced heart scans and routine health checks reveal previously unknown heart and other health issues in a vast majority of older adults.

Semaglutide can mitigate antipsychotic-induced metabolic dysfunction in patients with schizophrenia, prediabetes, and overweight or obesity on second-generation antipsychotics.

Acute kidney injury occurs in nearly one quarter of children at the onset of juvenile idiopathic arthritis and increases the risk for long-term kidney damage by more than five times.

News All Time

Experts Warn Psychiatric Symptoms May Mask Hidden Disease

Takotsubo syndrome, frontotemporal dementia, gut-brain disorders, and tinnitus share psychiatric features that complicate their diagnosis and management.

PCPs Key to Cardiac Amyloidosis Detection in Obese Patients

The signs may be subtle, but clinicians have clues to look for.

Statins After 80? Lower Death Risk With Heart Benefit

In adults aged 80 years or older, the use of statins is linked to a lower risk for all-cause mortality and new coronary events.

Paclitaxel Devices Should Not Be Routine for Claudication

An MHRA advisory group says paclitaxel-coated balloons and stents should not be used routinely for intermittent claudication over mortality concerns.

AHA, ACC Issue Comprehensive Guidelines on Acute PE

The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification system.

Therapy-Intense Training Linked to Improved Sleep Outcomes

Combining high-intensity circuit training with a sleep health program is tied to better sleep outcomes in sedentary women than either intervention alone, a new study shows.

Ramipril Batch Recalled After Amlodipine Found in Packs

The MHRA has recalled a batch of ramipril after a packaging error meant some cartons contained amlodipine tablets instead of the labelled medicine.

The Many Cardiovascular Benefits of GLP-1 Drugs

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down to weight loss.

Aspirin May Reduce Aortic Stenosis in People With High Lp(a)

New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis, specifically in people with high lipoprotein(a).

Diltiazem With Blood Thinners Tied to Bleeding Risk

Patients with atrial fibrillation who use diltiazem combined with apixaban or rivaroxaban face an increased risk for serious bleeding events compared with those who use metoprolol.

Kidney Biomarkers as Sentinels in COVID Prognosis

Derived from early pandemic waves and needing recalibration for new variants, these renal markers and IL 10 could act as sentinel biomarkers in other viral pneumonias.

Could Blood Pressure Meds Worsen Glaucoma Damage?

Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure.

Varenicline Use ‘Dismally Low’ in Smokers With PAD

Insurance and health record data showed about 3% of smokers with peripheral artery disease were prescribed the smoking cessation drug, despite the significant benefits of quitting.

Practical Answers to Everyday Infection Questions

Avoid unnecessary tests and antibiotics by applying evidence-based, cost-conscious infectious-disease decision-making, with practical guidance for common clinical scenarios.

SOUL: Oral Semaglutide Benefits Extend to Heart Failure

A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.